Janet Holbrook - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Nutrition, Epidemiology, Public Health

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tomkins-Netzer O, Lightman SL, Burke AE, Sugar EA, Lim LL, Jaffe GJ, Altaweel MM, Kempen JH, Holbrook JT, Jabs DA. Seven-year outcomes of uveitic macular edema: the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study results. Ophthalmology. PMID 32918964 DOI: 10.1016/j.ophtha.2020.08.035  0.32
2020 Kempen JH, Van Natta ML, Friedman DS, Altaweel MM, Ansari H, Dunn JP, Elner SG, Holbrook JT, Lim LL, Sugar EA, Jabs DA. Incidence and outcome of uveitic glaucoma in eyes with intermediate, posterior or panuveitis followed up to 10 years after randomization to fluocinolone acetonide implant or systemic therapy. American Journal of Ophthalmology. PMID 32628922 DOI: 10.1016/j.ajo.2020.06.038  0.32
2019 Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, ... ... Holbrook JT, et al. Visual Acuity Outcome over Time in Non-Infectious Uveitis. Ocular Immunology and Inflammation. 1-8. PMID 31821051 DOI: 10.1080/09273948.2019.1687733  0.32
2018 Thorne JE, Sugar EA, Holbrook JT, Burke AE, Altaweel MM, Vitale AT, Acharya NR, Kempen JH, Jabs DA. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Ophthalmology. PMID 30269924 DOI: 10.1016/j.ophtha.2018.08.021  0.32
2017 Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy. Ophthalmology. PMID 28624167 DOI: 10.1016/j.ophtha.2017.05.015  0.32
2017 Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis. Jama. PMID 28477440 DOI: 10.1001/jama.2017.5103  0.32
2016 Lang JE, Hossain J, Holbrook JT, Teague WG, Gold BD, Wise RA, Lima JJ. Gastro-oesophageal reflux and worse asthma control in obese children: a case of symptom misattribution? Thorax. PMID 26834184 DOI: 10.1136/thoraxjnl-2015-207662  0.68
2016 Yu T, Holbrook JT, Thorne JE, Puhan MA. Using a patient-centered approach to benefit-harm assessment in treatment decision-making: a case study in uveitis. Pharmacoepidemiology and Drug Safety. PMID 26798977 DOI: 10.1002/pds.3959  0.68
2015 Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis J, Jabs DA. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. American Journal of Ophthalmology. PMID 26748056 DOI: 10.1016/j.ajo.2015.12.028  0.32
2015 Quezada W, Kwak ES, Reibman J, Rogers L, Mastronarde J, Teague WG, Wei C, Holbrook JT, DiMango E. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. PMID 26712474 DOI: 10.1016/j.anai.2015.11.011  0.68
2015 Yu T, Hsu YJ, Fain KM, Boyd CM, Holbrook JT, Puhan MA. Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey. Bmj Open. 5: e007960. PMID 26614616 DOI: 10.1136/bmjopen-2015-007960  0.68
2015 Yu T, Holbrook JT, Thorne JE, Flynn TN, Van Natta ML, Puhan MA. Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study. Investigative Ophthalmology & Visual Science. 56: 6864-72. PMID 26501236 DOI: 10.1167/iovs.15-16705  0.68
2015 Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. PMID 26499920 DOI: 10.1016/j.ophtha.2015.09.022  0.32
2015 Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. American Journal of Ophthalmology. PMID 26386159 DOI: 10.1016/j.ajo.2015.09.017  0.32
2015 Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LB. Albuterol Overuse: A Marker of Psychological Distress? The Journal of Allergy and Clinical Immunology. in Practice. PMID 26341049 DOI: 10.1016/j.jaip.2015.06.021  0.68
2015 Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 122: 1967-75. PMID 26298715 DOI: 10.1016/j.ophtha.2015.06.042  0.48
2015 Lang JE, Holbrook JT, Lima JJ. Reply: Worsening Asthma Control in Children Taking Lansoprazole: Possible Mechanisms. Annals of the American Thoracic Society. 12: 1110-1. PMID 26203617 DOI: 10.1513/AnnalsATS.201505-298LE  0.68
2015 Smith LJ, Kalhan R, Wise RA, Sugar EA, Lima JJ, Irvin CG, Dozor AJ, Holbrook JT. Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial. Jama. 313: 2033-43. PMID 26010632 DOI: 10.1001/jama.2015.5024  0.68
2015 Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA. Reply. The Journal of Allergy and Clinical Immunology. PMID 25959669 DOI: 10.1016/j.jaci.2015.04.003  0.68
2015 Blake K, Holbrook JT, Antal H, Shade D, Bunnell HT, McCahan SM, Wise RA, Pennington C, Garfinkel P, Wysocki T. Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale. Contemporary Clinical Trials. 42: 105-18. PMID 25847579 DOI: 10.1016/j.cct.2015.03.012  0.68
2015 Lang JE, Holbrook JT, Mougey EB, Wei CY, Wise RA, Teague WG, Lima JJ. Lansoprazole Is Associated with Worsening Asthma Control in Children with the CYP2C19 Poor Metabolizer Phenotype. Annals of the American Thoracic Society. 12: 878-85. PMID 25844821 DOI: 10.1513/AnnalsATS.201408-391OC  0.68
2015 Dixon AE, Castro M, Cohen RI, Gerald LB, Holbrook JT, Irvin CG, Mohapatra S, Peters SP, Rayapudi S, Sugar EA, Wise RA. Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. The Journal of Allergy and Clinical Immunology. 135: 701-9.e5. PMID 25174863 DOI: 10.1016/j.jaci.2014.06.038  0.68
2014 Fitzpatrick AM, Holbrook JT, Wei CY, Brown MS, Wise RA, Teague WG. Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma. The Journal of Allergy and Clinical Immunology. in Practice. 2: 579-86.e7. PMID 25213052 DOI: 10.1016/j.jaip.2014.04.006  0.68
2014 Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies. Clinical Trials (London, England). 11: 635-47. PMID 25115882 DOI: 10.1177/1740774514547396  0.68
2014 Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 121: 1855-62. PMID 24908205 DOI: 10.1016/j.ophtha.2014.04.022  0.68
2014 Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M. Variability of methacholine bronchoprovocation and the effect of inhaled corticosteroids in mild asthma. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology. 112: 354-60.e1. PMID 24507830 DOI: 10.1016/j.anai.2014.01.013  0.68
2014 Nguyen JM, Holbrook JT, Wei CY, Gerald LB, Teague WG, Wise RA. Validation and psychometric properties of the Asthma Control Questionnaire among children. The Journal of Allergy and Clinical Immunology. 133: 91-7.e1-6. PMID 23932458 DOI: 10.1016/j.jaci.2013.06.029  0.68
2014 Drye LT, Casper AS, Sternberg AL, Holbrook JT, Jenkins G, Meinert CL. The transitioning from trials to extended follow-up studies Clinical Trials. 11: 635-647. DOI: 10.1177/1740774514547396  0.68
2013 Lang JE, Dozor AJ, Holbrook JT, Mougey E, Krishnan S, Sweeten S, Wise RA, Teague WG, Wei CY, Shade D, Lima JJ. Biologic mechanisms of environmental tobacco smoke in children with poorly controlled asthma: results from a multicenter clinical trial. The Journal of Allergy and Clinical Immunology. in Practice. 1: 172-80. PMID 24565456 DOI: 10.1016/j.jaip.2012.11.006  0.68
2013 McCallister JW, Holbrook JT, Wei CY, Parsons JP, Benninger CG, Dixon AE, Gerald LB, Mastronarde JG. Sex differences in asthma symptom profiles and control in the American Lung association asthma clinical research centers Respiratory Medicine. 107: 1491-1500. PMID 23972381 DOI: 10.1016/j.rmed.2013.07.024  0.68
2013 Lima JJ, Lang JE, Mougey EB, Blake KB, Gong Y, Holbrook JT, Wise RA, Teague WG. Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children. The Journal of Pediatrics. 163: 686-91. PMID 23623526 DOI: 10.1016/j.jpeds.2013.03.017  0.68
2013 Friedman DS, Holbrook JT, Ansari H, Alexander J, Burke A, Reed SB, Katz J, Thorne JE, Lightman SL, Kempen JH. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 120: 1571-9. PMID 23601801 DOI: 10.1016/j.ophtha.2013.01.025  0.68
2013 Lang JE, Holbrook JT, Wise RA, Dixon AE, Teague WG, Wei CY, Irvin CG, Shade D, Lima JJ. Obesity in children with poorly controlled asthma: Sex differences. Pediatric Pulmonology. 48: 847-56. PMID 23143849 DOI: 10.1002/ppul.22707  0.68
2012 Domalpally A, Altaweel MM, Kempen JH, Myers D, Davis JL, Foster CS, Latkany P, Srivastava SK, Stawell RJ, Holbrook JT. Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial. Ocular Immunology and Inflammation. 20: 443-7. PMID 23163490 DOI: 10.3109/09273948.2012.719258  0.68
2012 Bime C, Wei CY, Holbrook JT, Sockrider MM, Revicki DA, Wise RA. Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. The Journal of Allergy and Clinical Immunology. 130: 1078-84. PMID 23026499 DOI: 10.1016/j.jaci.2012.07.058  0.68
2012 Bime C, Wei CY, Holbrook J, Smith LJ, Wise RA. Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Primary Care Respiratory Journal : Journal of the General Practice Airways Group. 21: 398-404. PMID 22885561 DOI: 10.4104/pcrj.2012.00073  0.68
2012 Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, Kozak I, Holbrook JT, Jabs DA, Kempen JH. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocular Immunology and Inflammation. 20: 171-81. PMID 22530874 DOI: 10.3109/09273948.2012.658467  0.68
2012 Sumino K, Sugar EA, Irvin CG, Kaminsky DA, Shade D, Wei CY, Holbrook JT, Wise RA, Castro M. Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. The Journal of Allergy and Clinical Immunology. 130: 69-75.e6. PMID 22465214 DOI: 10.1016/j.jaci.2012.02.025  0.68
2012 Holbrook JT, Wise RA, Gold BD, Blake K, Brown ED, Castro M, Dozor AJ, Lima JJ, Mastronarde JG, Sockrider MM, Teague WG. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. Jama. 307: 373-81. PMID 22274684 DOI: 10.1001/jama.2011.2035  0.68
2012 Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Investigative Ophthalmology & Visual Science. 53: 1169-76. PMID 22247489 DOI: 10.1167/iovs.11-8259  0.68
2011 Holbrook JT, Kempen JH, Prusakowski NA, Altaweel MM, Jabs DA. Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials. Clinical Trials (London, England). 8: 736-43. PMID 21994128 DOI: 10.1177/1740774511423682  0.68
2011 Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE. Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology. 118: 1916-26. PMID 21840602 DOI: 10.1016/j.ophtha.2011.07.027  0.68
2011 Holbrook JT, Colvin R, Van Natta ML, Thorne JE, Bardsley M, Jabs DA. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis American Journal of Ophthalmology. 152: 628-637. PMID 21742304 DOI: 10.1016/j.ajo.2011.04.007  0.68
2010 Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. American Journal of Ophthalmology. 149: 550-561.e10. PMID 20097325 DOI: 10.1016/j.ajo.2009.11.019  0.32
2009 Wise RA, Bartlett SJ, Brown ED, Castro M, Cohen R, Holbrook JT, Irvin CG, Rand CS, Sockrider MM, Sugar EA. Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. The Journal of Allergy and Clinical Immunology. 124: 436-44, 444e1-8. PMID 19632710 DOI: 10.1016/j.jaci.2009.05.041  0.68
2009 Beasley JM, Ange BA, Anderson CA, Miller ER, Erlinger TP, Holbrook JT, Sacks FM, Appel LJ. Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the Optimal Macronutrient Intake Trial to Prevent Heart Disease. American Journal of Epidemiology. 169: 893-900. PMID 19224977 DOI: 10.1093/aje/kwn415  0.68
2009 Beasley JM, Ange BA, Anderson CA, Miller Iii ER, Holbrook JT, Appel LJ. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin). Obesity (Silver Spring, Md.). 17: 349-54. PMID 19057526 DOI: 10.1038/oby.2008.551  0.68
2007 Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 114: 780-6. PMID 17258320 DOI: 10.1016/j.ophtha.2006.11.008  0.68
2007 Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology. 114: 787-93. PMID 17210182 DOI: 10.1016/j.ophtha.2006.07.065  0.68
2007 Thorne JE, Holbrook JT, Jabs DA, Kempen JH, Nichols C, Meinert CL. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 114: 591-8. PMID 17123624 DOI: 10.1016/j.ophtha.2006.08.008  0.68
2006 Dixon AE, Shade DM, Cohen RI, Skloot GS, Holbrook JT, Smith LJ, Lima JJ, Allayee H, Irvin CG, Wise RA. Effect of obesity on clinical presentation and response to treatment in asthma. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 43: 553-8. PMID 16939998 DOI: 10.1080/02770900600859123  0.68
2006 Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1441-5. PMID 16781775 DOI: 10.1016/j.ophtha.2006.03.022  0.68
2006 Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology. 113: 1432-40. PMID 16766032 DOI: 10.1016/j.ophtha.2006.03.021  0.68
2006 Lima JJ, Holbrook JT, Wang J, Sylvester JE, Blake KV, Blumenthal MN, Castro M, Hanania N, Wise R. The C523A beta2 adrenergic receptor polymorphism associates with markers of asthma severity in African Americans. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 43: 185-91. PMID 16754519 DOI: 10.1080/02770900600566611  0.68
2006 Stone JH, Holbrook JT, Marriott MA, Tibbs AK, Sejismundo LP, Min YI, Specks U, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune WJ, Ytterberg SR, Allen NB, Hoffman GS, et al. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. Arthritis and Rheumatism. 54: 1608-18. PMID 16646004 DOI: 10.1002/art.21869  0.68
2006 Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, Wang J, Sylvester J, Holbrook J, Wise R, Weiss ST, Barnes K. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. American Journal of Respiratory and Critical Care Medicine. 173: 379-85. PMID 16293801 DOI: 10.1164/rccm.200509-1412OC  0.68
2005 Jabs DA, Holbrook JT, Van Natta ML, Clark R, Jacobson MA, Kempen JH, Murphy RL. Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology. 112: 771-9. PMID 15878056 DOI: 10.1016/j.ophtha.2004.10.049  0.68
2005 Weinberg DV, Holbrook JT, Hubbard LD, Davis MD, Jabs DA, Holland GN. Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 112: 559-66. PMID 15808244 DOI: 10.1016/j.ophtha.2004.11.027  0.32
2004 Smith LJ, Holbrook JT, Wise R, Blumenthal M, Dozor AJ, Mastronarde J, Williams L. Dietary intake of soy genistein is associated with lung function in patients with asthma. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 41: 833-43. PMID 15641633 DOI: 10.1081/JAS-200038447  0.68
2004 Hanania NA, Sockrider M, Castro M, Holbrook JT, Tonascia J, Wise R, Atmar RL. Immune response to influenza vaccination in children and adults with asthma: Effect of corticosteroid therapy Journal of Allergy and Clinical Immunology. 113: 717-724. PMID 15100679 DOI: 10.1016/j.jaci.2003.12.584  0.68
2003 Gilpin AM, Holbrook JT, Jabs DA, Meinert CL. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Controlled Clinical Trials. 24: 92-8. PMID 12559647 DOI: 10.1016/S0197-2456(02)00268-4  0.68
2003 Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy. Archives of Ophthalmology (Chicago, Ill. : 1960). 121: 99-107. PMID 12523893  0.32
2002 Davidson M, Min YI, Holbrook JT, Van Natta M, Quinn TC, Murphy RL, Welch W, Jabs DA, Meinert CL. Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. The Journal of Infectious Diseases. 186: 1013-8. PMID 12232843 DOI: 10.1086/342956  0.68
2002 Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. Aids (London, England). 16: 757-65. PMID 11964532 DOI: 10.1097/00002030-200203290-00011  0.68
2001 Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients Archives of Ophthalmology. 119: 554-563. PMID 11296021  0.68
2001 Holbrook JT, Meinert CL, Jabs DA. Patient notification and follow-up after suspension of treatment protocols: Experience from four clinical trials of treatments for AIDS-related CMV retinitis Controlled Clinical Trials. 22: 62-68. PMID 11165425 DOI: 10.1016/S0197-2456(00)00112-4  0.68
2000 Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome Archives of Ophthalmology. 118: 1196-1204. PMID 10980764 DOI: 10.1001/archopht.118.9.1196  0.68
1993 Dieterich DT, Poles MA, Lew EA, Mendez PE, Murphy R, Addessi A, Holbrook JT, Naughton K, Friedberg DN. Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients. The Journal of Infectious Diseases. 167: 1184-8. PMID 8387563 DOI: 10.1093/infdis/167.5.1184  0.68
1992 Holbrook JT, Meinert CL. Crisis management: A coordinating center's experience with the suspension of a aids treatment protocol for a clinical trial Controlled Clinical Trials. 13: 394.  0.68
Show low-probability matches.